OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
242558

Care Service Co Ltd

Healthcare Facilities & ServicesVerified

Care Service Co. Ltd. maintains a strong liquidity position with a current ratio of 3.7, indicating the company can easily cover its short-term obligations. The company's cash and equivalents amount to ¥1.84 billion, significantly exceeding its total liabilities of ¥1.196 billion. The low debt-to-equity ratio of 0.02 suggests a conservative capital structure with minimal leverage. Profitability metrics show the company is performing well relative to industry norms. A return on equity (ROE) of 12.79% and a return on assets (ROA) of 9.08% indicate efficient use of equity and assets to generate profit. These figures are well above the typical thresholds for the healthcare services sector, suggesting strong operational performance. The company's revenue is distributed across three segments: Nursing Care, Angel Care, and Houses with Services for the Elderly. While the exact revenue contribution of each segment is not disclosed, the diversified approach helps mitigate risks associated with over-reliance on a single service line. The geographic exposure is primarily concentrated in Japan, with no material international operations reported. Looking ahead, the company is expected to maintain its growth trajectory. The most recent financial data shows a revenue of ¥9.86 billion, and while specific forward-looking guidance is not provided, the company's strong cash flow and low debt position support continued expansion. The operating cash flow of ¥554 million and free cash flow of ¥330 million provide flexibility for reinvestment or shareholder returns. The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt levels and strong cash reserves reduce the likelihood of financial distress. Additionally, the absence of dilution risk suggests that the company is not planning significant equity issuances in the near term. Recent events, including the latest financial filings and transcripts, do not highlight any material changes in the company's operations or strategic direction. The company continues to focus on its core nursing care services, with no indication of major restructuring or new market entry.

30-day price · 2425(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyCare Service Co Ltd
Ticker2425.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Care Service Co., Ltd. provides nursing care services in Japan, operating through three segments: Nursing Care, Angel Care, and Houses with Services for the Elderly.

Classification. The company is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a confidence level of 0.92.

Care Service Co. Ltd. maintains a strong liquidity position with a current ratio of 3.7, indicating the company can easily cover its short-term obligations. The company's cash and equivalents amount to ¥1.84 billion, significantly exceeding its total liabilities of ¥1.196 billion. The low debt-to-equity ratio of 0.02 suggests a conservative capital structure with minimal leverage. Profitability metrics show the company is performing well relative to industry norms. A return on equity (ROE) of 12.79% and a return on assets (ROA) of 9.08% indicate efficient use of equity and assets to generate profit. These figures are well above the typical thresholds for the healthcare services sector, suggesting strong operational performance. The company's revenue is distributed across three segments: Nursing Care, Angel Care, and Houses with Services for the Elderly. While the exact revenue contribution of each segment is not disclosed, the diversified approach helps mitigate risks associated with over-reliance on a single service line. The geographic exposure is primarily concentrated in Japan, with no material international operations reported. Looking ahead, the company is expected to maintain its growth trajectory. The most recent financial data shows a revenue of ¥9.86 billion, and while specific forward-looking guidance is not provided, the company's strong cash flow and low debt position support continued expansion. The operating cash flow of ¥554 million and free cash flow of ¥330 million provide flexibility for reinvestment or shareholder returns. The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The company's low debt levels and strong cash reserves reduce the likelihood of financial distress. Additionally, the absence of dilution risk suggests that the company is not planning significant equity issuances in the near term. Recent events, including the latest financial filings and transcripts, do not highlight any material changes in the company's operations or strategic direction. The company continues to focus on its core nursing care services, with no indication of major restructuring or new market entry.
Key takeaways
  • Strong liquidity position with a current ratio of 3.7 and ¥1.84 billion in cash and equivalents.
  • High profitability with ROE of 12.79% and ROA of 9.08%.
  • Diversified business model across three segments reduces operational risk.
  • Low debt-to-equity ratio of 0.02 indicates a conservative capital structure.
  • No immediate liquidity or dilution risks detected in the latest filings.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$9.86B
Gross profit$1.32B
Operating income$492.5M
Net income$374.0M
R&D
SG&A
D&A
SBC
Operating cash flow$553.9M
CapEx-$137.4M
Free cash flow$330.4M
Total assets$4.12B
Total liabilities$1.20B
Total equity$2.92B
Cash & equivalents$1.84B
Long-term debt$67.3M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.92B
Net cash$1.78B
Current ratio3.7
Debt/Equity0.0
ROA9.1%
ROE12.8%
Cash conversion1.5%
CapEx/Revenue-1.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
Metric2425Activity
Op margin5.0%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin3.8%14.7% medp25 11.7% · p75 28.1%bottom quartile
Gross margin13.4%19.7% medp25 19.7% · p75 39.8%bottom quartile
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-1.4%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity2.0%71.3% medp25 19.0% · p75 91.7%bottom quartile
Observations
IR observations
Last actual EPS98.60 JPY
Last actual revenue9,862,200,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 06:47 UTC#35ab0047
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 06:49 UTCJob: 3d189d31